The Efficacy of Cimetropium Bromide during Colonoscopy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001006

Enrollment

700

Registered

2014-02-21

Start date

2014-02-05

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : 1) cimetropium bromide, 5mg(1cc), once , at the time of cecal intubation, intravenously 2) normal saline, 1cc, 1?, once , at the time of cecal intubation, intravenously

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who will undergo colonoscopy for the evaluation of colonic diseases

Exclusion criteria

Exclusion criteria: Pregnant, Patients under 18 years old or equal to/more than 75 years old, patient who received anticholinergic agents recently, allergic reaction about the drug, glaucoma, obstructive uropathy, myathenia gravis, autonomic neuropathy, the history of arrhythmia, the past history of bowel resection operation

Design outcomes

Primary

Measure	Time frame
Polyp detection rate;Adenoma detection rate;Rt. colon adenoma detection rate;Rt. colon polyp detection rate	—

Secondary

Measure	Time frame
Bowel preparation;Insertion time, ;Withdrawl time;The total number of polyp	—

Countries

Korea, Republic of

Contacts

Public ContactSu Bum Park

Pusan National University Yangsan Hospital

Outcome results